|

ABSK-011+BSC Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Abbisko Therapeutics Co, Ltd1

Indications

  • Liver Disease1
  • Hepatocellular Carcinoma (HCC)1
  • Liver Cancer1
  • Cancer1

Other1 trial

ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 Overexpression
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.